OneThree BioTech
Drug Discovery, Powered by AI
New York, United States · $2.5M raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Website
- onethreebio.squarespace.com
- Total Funding
- $2.5M
- Last Round
- $2.5M SeedMar 2020
- Rounds
- 1
About
AI-driven drug discovery and development company using AI to identify novel targets and generate testable insights for drug developers.
Summary
OneThree BioTech is an Artificial Intelligence company based in New York, United States. It has raised $2.5M in total across 1 round, most recently a $2.5M Seed round in Mar 2020. Investors include Primary VC and Meridian Street Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2020
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.